HK1054334B - 含有丙烯酰司他霉素衍生物以及拓扑异构酶i和ii抑制剂的药物组合物 - Google Patents

含有丙烯酰司他霉素衍生物以及拓扑异构酶i和ii抑制剂的药物组合物 Download PDF

Info

Publication number
HK1054334B
HK1054334B HK03106770.0A HK03106770A HK1054334B HK 1054334 B HK1054334 B HK 1054334B HK 03106770 A HK03106770 A HK 03106770A HK 1054334 B HK1054334 B HK 1054334B
Authority
HK
Hong Kong
Prior art keywords
amino
topoisomerase
methyl
inhibitor
formula
Prior art date
Application number
HK03106770.0A
Other languages
English (en)
Chinese (zh)
Other versions
HK1054334A1 (en
Inventor
M‧C‧R‧杰龙尼
M‧C‧R‧傑龍尼
P‧库兹
I‧博利亚
P‧庫茲
I‧博利亞
Original Assignee
内尔维阿诺医学科学有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 内尔维阿诺医学科学有限公司 filed Critical 内尔维阿诺医学科学有限公司
Publication of HK1054334A1 publication Critical patent/HK1054334A1/xx
Publication of HK1054334B publication Critical patent/HK1054334B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK03106770.0A 2000-06-23 2001-06-20 含有丙烯酰司他霉素衍生物以及拓扑异构酶i和ii抑制剂的药物组合物 HK1054334B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0015444.3A GB0015444D0 (en) 2000-06-23 2000-06-23 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors
GB0015444.3 2000-06-23
PCT/EP2001/007059 WO2001097789A2 (en) 2000-06-23 2001-06-20 Pharmaceutical compositions comprising acryloyl distamycin derivatives and topoisomerase i and ii inhibitors

Publications (2)

Publication Number Publication Date
HK1054334A1 HK1054334A1 (en) 2003-11-28
HK1054334B true HK1054334B (zh) 2006-09-22

Family

ID=9894285

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03106770.0A HK1054334B (zh) 2000-06-23 2001-06-20 含有丙烯酰司他霉素衍生物以及拓扑异构酶i和ii抑制剂的药物组合物

Country Status (27)

Country Link
US (1) US20030162722A1 (enExample)
EP (1) EP1292290B1 (enExample)
JP (1) JP2003535890A (enExample)
KR (1) KR100853955B1 (enExample)
CN (1) CN1241573C (enExample)
AT (1) ATE323483T1 (enExample)
AU (2) AU2001278463B2 (enExample)
BR (1) BR0111813A (enExample)
CA (1) CA2411172C (enExample)
CZ (1) CZ20024155A3 (enExample)
DE (1) DE60118914T2 (enExample)
DK (1) DK1292290T3 (enExample)
EA (1) EA006684B1 (enExample)
EE (1) EE05319B1 (enExample)
ES (1) ES2261448T3 (enExample)
GB (1) GB0015444D0 (enExample)
HK (1) HK1054334B (enExample)
HU (1) HUP0301257A2 (enExample)
IL (1) IL153177A0 (enExample)
MX (1) MXPA02012163A (enExample)
NO (1) NO329783B1 (enExample)
NZ (1) NZ523000A (enExample)
PL (1) PL200503B1 (enExample)
PT (1) PT1292290E (enExample)
SK (1) SK287549B6 (enExample)
WO (1) WO2001097789A2 (enExample)
ZA (1) ZA200209834B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0015444D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors
GB0015447D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents
PL371179A1 (en) * 2002-01-02 2005-06-13 Pharmacia Italia S.P.A. Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors
CN100438913C (zh) * 2004-11-22 2008-12-03 山东蓝金生物工程有限公司 一种抗癌药物组合物
MD35Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de apreciere a riscului dezvoltării carcinomului neinvaziv in situ al glandei mamare
MD36Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului ductal in situ neinvaziv al glandei mamare
MD24Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului neinvaziv al glandei mamare
MD23Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului lobular in situ neinvaziv al glandei mamare
CA2803646A1 (en) 2010-07-02 2012-01-05 Angiochem Inc. Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof
CN109718228A (zh) * 2017-10-30 2019-05-07 沈阳药科大学 米托蒽醌的抗肿瘤淋巴转移作用及其药物制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9615692D0 (en) * 1996-07-25 1996-09-04 Pharmacia Spa Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
GB9623522D0 (en) * 1996-11-11 1997-01-08 Pharmacia & Upjohn Spa Benzoheterocycle distamycin derivatives process for preparing them and their use as antitumour and antiviral agents
GB9727524D0 (en) * 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Synergistic antitumor composition containing a biologically active ureido compound
GB9806692D0 (en) * 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Benzoheterocyclic distamycin derivatives, process for preparing them and their use as antitumour agents
GB0015444D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors

Also Published As

Publication number Publication date
HUP0301257A2 (hu) 2003-08-28
CA2411172A1 (en) 2001-12-27
WO2001097789A2 (en) 2001-12-27
KR100853955B1 (ko) 2008-08-25
CZ20024155A3 (cs) 2003-04-16
ATE323483T1 (de) 2006-05-15
AU7846301A (en) 2002-01-02
EA200300060A1 (ru) 2003-04-24
US20030162722A1 (en) 2003-08-28
PT1292290E (pt) 2006-08-31
MXPA02012163A (es) 2003-04-25
DE60118914T2 (de) 2006-12-21
CA2411172C (en) 2009-11-17
ZA200209834B (en) 2003-12-04
CN1241573C (zh) 2006-02-15
HK1054334A1 (en) 2003-11-28
ES2261448T3 (es) 2006-11-16
AU2001278463B2 (en) 2006-02-23
EP1292290A2 (en) 2003-03-19
EE05319B1 (et) 2010-08-16
JP2003535890A (ja) 2003-12-02
PL360297A1 (en) 2004-09-06
SK287549B6 (sk) 2011-01-04
NZ523000A (en) 2005-12-23
EA006684B1 (ru) 2006-02-24
SK18332002A3 (sk) 2003-07-01
BR0111813A (pt) 2003-05-20
WO2001097789A3 (en) 2002-05-16
IL153177A0 (en) 2003-06-24
NO20026078D0 (no) 2002-12-18
NO20026078L (no) 2002-12-18
EE200200681A (et) 2004-06-15
DK1292290T3 (da) 2006-07-10
KR20030019448A (ko) 2003-03-06
EP1292290B1 (en) 2006-04-19
CN1437474A (zh) 2003-08-20
PL200503B1 (pl) 2009-01-30
DE60118914D1 (de) 2006-05-24
NO329783B1 (no) 2010-12-13
GB0015444D0 (en) 2000-08-16

Similar Documents

Publication Publication Date Title
KR20010102364A (ko) 상승작용성 항종양 조성물
HK1045462A1 (en) Combined preparations comprising morpholine anthracyclines and anticancer agent
CN1241573C (zh) 含有丙烯酰司他霉素衍生物以及拓扑异构酶ⅰ和ⅱ抑制剂的药物组合物
AU2001278463A1 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase i and ii inhibitors
HK1054193A1 (en) Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione
CN1437485A (zh) 包含取代的丙烯酰基偏端霉素衍生物和烷基化剂的抗肿瘤联合疗法
EP1889624B1 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites
AU2001281867A1 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents
US20070249651A1 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors
HK1072899A (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors
HK1060312A (en) Antitumor therapy comprising distamycin derivatives
HK1058623A1 (en) A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
HK1058623B (en) A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
HK1068786A (en) Combined preparations comprising anthracycline derivatives
HK1096867A (en) Combined preparations comprising anthracycline derivatives
HK1096538A (en) Combined preparations comprising anthracycline derivatives
HK1065252A (en) Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110620